Press Releases - 2005

Gamida Cell CEO To Present on “Expanded Stem Cell Therapeutics: Status and Progress” at the UBS Conference at the Grand Hyatt in NY, September 26, 2005
Sep. 22, 2005

Gamida Cell Names Dr. Yael Margolin as the Company’s New President and CEO StemEx® Receives FDA Orphan Drug Designation
Mar. 15, 2005

Teva and Gamida-Cell Will Develop and Commercialize StemEx® for the Treatment of Leukemia
Feb. 16, 2005

Preparations Underway to Commence Phase II/III Study

Press Releases Archive

• Recent
• 2008
• 2007
• 2006
• 2005
• 2004
• 2003

To learn more about our products and clinical trials, please fill in:
*	Name:
*	Email:
	Country:
*	Message:
*	Please type in the verification code as appears on the image: